🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy, safety, and tolerabili...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01399125
The purpose of this study was to investigate the 5cm\^2 and 10cm\^2 doses o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2007-01
Trial ID
NCT00423085
Treatments Being Tested
The core study assessed the efficacy of a higher dose of rivastigmine 13.3 ...
Status
Completed
Location
Clinical Research Advantage Inc./Neurological. Physicians of Arizona, Inc
Start Date
2009-07
Trial ID
NCT00948766
The aim of this study is to evaluate the efficacy of an anticholinesterase ...
Status
Completed
Location
Pitié Salpetriere Hospital
Start Date
2011-06
Trial ID
NCT01487317
Treatments Being Tested
Mild cognitive impairment, including difficulty with solving problems, plan...
Status
Completed
Location
University of Pennsylvania, Ralston House
Start Date
2011-12
Trial ID
NCT01519271
Treatments Being Tested
Auditory hallucinations are among the most distressing aspects of psychotic...
Status
Recruiting
Location
Connecticut Mental Health Center
Start Date
2021-07-15
Trial ID
NCT04366518
Treatments Being Tested
The purpose of this multicenter trial is to assess the efficacy and safety ...
Status
Terminated
Location
Multiple Locations
Start Date
2013-10-22
Trial ID
NCT01852110
The purpose of this study was to support the optimal use of rivastigmine pa...
Status
Completed
Location
Novartis investigative site
Start Date
2007-06
Trial ID
NCT00506415
This is a 24-week prospective, randomized, double-blind, placebo-controlled...
Status
Recruiting
Location
Santa Lucia Foundation
Start Date
2023-12-01
Trial ID
NCT06702124
Treatments Being Tested
This study evaluated the efficacy and safety of 10 cm² rivastigmine patch v...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2009-04
Trial ID
NCT00881205
Treatments Being Tested